Neutropenia and efficacy outcomes in patients with refractory mCRC: a post-hoc analysis of the phase III SUNLIGHT trial

Real-world progression-free and overall survival of patients with metastatic colorectal cancer according to first and second-line treatment regimen: PROMETCO study

Comparison of the efficacy of third-line treatments for metastatic colorectal cancer: A network meta-analysis

Real-world evidence of FTD/TPI and bevacizumab combination therapy in metastatic colorectal cancer: Survival and clinicopathological insights

Real-world data on overall and progression-free survival for patients (Pts) with metastatic colorectal cancer (mCRC) for the United Kingdom (UK) cohort of the PROMETCO study (PROMETCO UK)